{"id":198934,"name":"AVANIR PHARMACEUTICALS","slug":"avanir-pharmaceuticals","state":"CA","country":"United States of America","description":"","totalSpending":410000,"filings":7,"yearlySpending":[{"year":2021,"income":140000},{"year":2022,"income":270000}],"issues":["HCR","MED","VET","MMM","BUD"],"firms":["AVANIR PHARMACEUTICALS"],"lobbyists":["CATHERINE FERGUSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid.","Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid.","Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid.","Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid.","Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid."],"years":[2021,2022]}